Jiang Pi
Impact in
- Drug Discovery top 0.5%
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Tuberculosis Research and Epidemiology 28
- Biomaterials 22
- Nanoparticle-Based Drug Delivery 21
- Co-authors
- Jinhuan Jiang (19 shared papers)Hua Jin (46 shared papers)Jiye Cai (43 shared papers)Jun‐Fa Xu (30 shared papers)Fen Yang (32 shared papers)Huaihong Cai (20 shared papers)Peihui Yang (14 shared papers)Shuhao Fan (15 shared papers)
- Journals
- Frontiers in Immunology (8 papers)Frontiers in Pharmacology (6 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Pharmaceutics (4 papers)Journal of Nanobiotechnology (4 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Jiang Pi
114 papers receiving 4.8k citations
Jiang Pi's Hit Papers
Peers
Comparison fields: 5 of 122
- Drug Discovery 51
- Biomaterials 911
- Materials Chemistry 1.1k
- Pharmaceutical Science 162
- Infectious Diseases 359
Countries citing papers authored by Jiang Pi
This map shows the geographic impact of Jiang Pi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Pi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Pi more than expected).
Fields of papers citing papers by Jiang Pi
This network shows the impact of papers produced by Jiang Pi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Pi. The network helps show where Jiang Pi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiang Pi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications Hit paper breakdown → | 2018 | 1042 |
| 2 | 2020 | 310 | |
| 3 | 2023 | 141 | |
| 4 | 2016 | 130 | |
| 5 | 2017 | 115 | |
| 6 | 2021 | 111 | |
| 7 | 2019 | 109 | |
| 8 | 2017 | 91 | |
| 9 | 2022 | 90 | |
| 10 | 2014 | 86 | |
| 11 | 2012 | 82 | |
| 12 | 2016 | 81 | |
| 13 | 2018 | 77 | |
| 14 | 2013 | 76 | |
| 15 | 2012 | 71 | |
| 16 | 2022 | 70 | |
| 17 | 2016 | 68 | |
| 18 | 2019 | 67 | |
| 19 | 2021 | 66 | |
| 20 | 2022 | 66 |
About Jiang Pi
Jiang Pi is a scholar working on Infectious Diseases, Biomaterials, Biomedical Engineering, Cell Biology and Molecular Biology, having authored 121 papers that have together received 4.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (28 papers), Nanoparticle-Based Drug Delivery (21 papers), Nanoplatforms for cancer theranostics (11 papers), Force Microscopy Techniques and Applications (9 papers), Nanoparticles: synthesis and applications (8 papers), Gold and Silver Nanoparticles Synthesis and Applications (7 papers), Cellular Mechanics and Interactions (7 papers) and Advanced Drug Delivery Systems (5 papers). The work is most often cited by research in Drug Discovery (51 citations), Biomaterials (911 citations), Materials Chemistry (1.1k citations), Pharmaceutical Science (162 citations) and Infectious Diseases (359 citations). Jiang Pi has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Jinhuan Jiang, Hua Jin, Jiye Cai, Jun‐Fa Xu, Fen Yang, Huaihong Cai, Peihui Yang, Shuhao Fan, Colin E. Evans and Junai Zhang. Their work appears in journals such as Frontiers in Immunology, Frontiers in Pharmacology, Bioorganic & Medicinal Chemistry Letters, Pharmaceutics and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.